Milošević, Ivana (58456808200)Ivana (58456808200)MiloševićKarić, Uroš (57201195591)Uroš (57201195591)KarićPešić-Pavlović, Ivana (36473869000)Ivana (36473869000)Pešić-PavlovićStevanović, Goran (15059280200)Goran (15059280200)StevanovićBarać, Aleksandra (55550748700)Aleksandra (55550748700)BaraćSmiljanić, Marijana (57195930591)Marijana (57195930591)SmiljanićArsenović, Aleksandra (8559402600)Aleksandra (8559402600)ArsenovićStevanović, Olja (57201195181)Olja (57201195181)StevanovićĐonin-Nenezić, Miljana (57201195027)Miljana (57201195027)Đonin-NenezićBrmbolić, Branko (6701712863)Branko (6701712863)Brmbolić2025-06-122025-06-122018https://doi.org/10.3855/jidc.10257https://www.scopus.com/inward/record.uri?eid=2-s2.0-85043758182&doi=10.3855%2fjidc.10257&partnerID=40&md5=0796c1270c6ef890eac5d6dc4a7297cehttps://remedy.med.bg.ac.rs/handle/123456789/6538We present the first case of successful direct acting antiviral therapy of chronic hepatitis C in a hemodialysis patient in Serbia. The patient infected with genotype 1a has been successfully treated with Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir and Ribavirin. There are only a few real world reports regarding this therapeutic option in hemodialysis patients. © 2018 Milošević et al.3D regimenChronic hepatitis CHemodialysis